Literature DB >> 33489695

An autopsy case of Trousseau's syndrome with tumor thrombosis in unknown primary squamous cell carcinoma of the head and neck.

Kensuke Uraguchi1,2, Kenichi Kozakura2, Maki Fukuda3, Hidenori Marunaka1, Akira Doi2, Tsuyoshi Ohta3, Jun Iwata4, Shin Kariya1.   

Abstract

Trousseau's syndrome (TS) and tumor thrombosis (TT) are known as cancer-associated thrombosis with poor prognosis. TS is extremely rare in patients with squamous cell carcinoma. In this study, we report an unknown primary squamous cell carcinoma of the head and neck (SCCHN) patient with TS and TT in pulmonary artery definitely diagnosed by autopsy. A 73-year-old man had a past surgical history for unknown primary SCCHN and lung metastases. Three years after the initial surgery, the patient had multiple cerebral infarction, deep venous thrombosis in the legs and mediastinum metastases. Our diagnosis was TS and treatment with chemotherapy and unfractionated molecular heparin started. It could help control the hypercoagulative state and cancer progression, but finally, he died from progressive disease (mediastinum metastases and pulmonary embolism) five years after the initial surgery. An autopsy revealed multiple metastases and thrombosis in the pulmonary artery with squamous cell carcinoma microscopically. Although there is no established treatment for managing TS, intensive therapy such as a combination of chemotherapy and anticoagulant therapy can be effective in improving hypercoagulation therapy. In addition, an autopsy should be considered for patients with thrombosis to distinguish between TS and TT. © The Japan Society of Clinical Oncology 2020.

Entities:  

Keywords:  Cancer-associated thrombosis; Carcinoma of unknown primary; Squamous cell carcinoma; Trousseau’s syndrome; Tumor thrombosis

Year:  2020        PMID: 33489695      PMCID: PMC7797400          DOI: 10.1007/s13691-020-00440-4

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  16 in total

Review 1.  Trousseau's syndrome: multiple definitions and multiple mechanisms.

Authors:  Ajit Varki
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

Review 2.  Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine.

Authors:  Franco Dammacco; Angelo Vacca; Pasquale Procaccio; Roberto Ria; Ilaria Marech; Vito Racanelli
Journal:  Clin Exp Med       Date:  2013-03-02       Impact factor: 3.984

3.  Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases.

Authors:  Hironori Uruga; Takeshi Fujii; Atsuko Kurosaki; Shigeo Hanada; Hisashi Takaya; Atsushi Miyamoto; Nasa Morokawa; Sakae Homma; Kazuma Kishi
Journal:  Intern Med       Date:  2013       Impact factor: 1.271

Review 4.  Stroke in patients with cancer: incidence and etiology.

Authors:  D M Cestari; D M Weine; K S Panageas; A Z Segal; L M DeAngelis
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

Review 5.  Trousseau's syndrome: cancer-associated thrombosis.

Authors:  Soichiro Ikushima; Ryu Ono; Kensuke Fukuda; Masashi Sakayori; Nobuyasu Awano; Keisuke Kondo
Journal:  Jpn J Clin Oncol       Date:  2015-11-06       Impact factor: 3.019

6.  Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.

Authors:  Barbara Burtness; Kevin J Harrington; Richard Greil; Denis Soulières; Makoto Tahara; Gilberto de Castro; Amanda Psyrri; Neus Basté; Prakash Neupane; Åse Bratland; Thorsten Fuereder; Brett G M Hughes; Ricard Mesía; Nuttapong Ngamphaiboon; Tamara Rordorf; Wan Zamaniah Wan Ishak; Ruey-Long Hong; René González Mendoza; Ananya Roy; Yayan Zhang; Burak Gumuscu; Jonathan D Cheng; Fan Jin; Danny Rischin
Journal:  Lancet       Date:  2019-11-01       Impact factor: 79.321

7.  Pulmonary Tumor Thrombotic Microangiopathy Caused by a Parotid Tumor: Early Antemortem Diagnosis and Long-term Survival.

Authors:  Haruka Toyonaga; Michiko Tsuchiya; Chikara Sakaguchi; Hitomi Ajimizu; Yosuke Nakanishi; Seiya Nishiyama; Noboru Morikawa; Yasuyuki Hayashi; Yukio Nagasaka; Hiroshi Yasui
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

8.  Trousseau syndrome in a patient with advanced oral squamous cell carcinoma: a case report.

Authors:  Ken-Ichi Aoyama; Masashi Tamura; Masahiro Uchibori; Yasuhiro Nakanishi; Toshihiro Arai; Takayuki Aoki; Yuko Osawa; Akihiro Kaneko; Yoshihide Ota
Journal:  J Med Case Rep       Date:  2019-01-29

9.  Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141).

Authors:  Chia-Jui Yen; Naomi Kiyota; Nobuhiro Hanai; Shunji Takahashi; Tomoya Yokota; Shigemichi Iwae; Yasushi Shimizu; Ruey-Long Hong; Masahiro Goto; Jin-Hyoung Kang; Wing Sum Kenneth Li; Robert L Ferris; Maura Gillison; Toshimitsu Endo; Vijayvel Jayaprakash; Makoto Tahara
Journal:  Head Neck       Date:  2020-06-24       Impact factor: 3.147

10.  Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors.

Authors:  Yosuke Ando; Takahiro Hayashi; Reiko Sugimoto; Seira Nishibe; Kaori Ito; Kenji Kawada; Yoshiaki Ikeda; Shigeki Yamada; Kazuyoshi Imaizumi
Journal:  Invest New Drugs       Date:  2019-12-10       Impact factor: 3.850

View more
  1 in total

1.  Pulmonary tumor embolism: A retrospective study over a 30-year period.

Authors:  Xin He; Douglas C Anthony; Zulmira Catoni; Weibiao Cao
Journal:  PLoS One       Date:  2021-08-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.